Rg1 has been shown to improve neurological diseases through a variety of pharmacological effects, including apoptosis, miRNA, neuroinflammation, oxidative stress, the MAPK family, NF-κB, and learning and memory. This evidence concerns the gene NFKB1 and nervous system disorder.